Elizabeth Garrett-Mayer to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.047
-
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20; 32(12):1277-80.
Score: 0.027
-
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):203-11.
Score: 0.020